Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Trends in retinopathy of prematurity over a 5-year period in a racially diverse population.

Authors:
Irena Tsui Edward Ebani Jamie B Rosenberg Robert M Angert Juan Lin Umar Mian

Ophthalmic Surg Lasers Imaging Retina 2014 Mar-Apr;45(2):138-42

Background And Objective: Retinopathy of prematurity presents differently in developing versus developed countries, which may be due to environmental as well as racial differences.

Patients And Methods: Retrospective chart review of infants screened for ROP at a single neonatal intensive care unit. Risk factors were reviewed. Main outcome measures were rates of plus disease or treatment-requiring ROP by race.

Results: The study included 497 infants screened for ROP in an urban neonatal intensive care unit. Gestational age, birth weight, and bronchopulmonary dysplasia were independent risk factors for both plus disease and treatment-requiring ROP with type 3 multivariate analysis. Self-identified white race was also a risk factor for plus disease and treatment-requiring ROP. Race was significantly associated with maternal age, multiple births, and blood transfusions.

Conclusion: In the study population, white race was an independent risk factor for plus disease and ROP treatment.

Download full-text PDF

 Source
http://dx.doi.org/10.3928/23258160-20140306-07DOI Listing
September 2014

Publication Analysis

Top Keywords

treatment-requiring rop
12
disease treatment-requiring
12
independent risk
8
factor disease
8
risk factor
8
risk factors
8
white race
8
neonatal intensive
8
retinopathy prematurity
8
screened rop
8
care unit
8
intensive care
8
infants screened
8
rop
6
unit gestational
4
included 497
4
raceresults study
4
rop urban
4
497 infants
4
urban neonatal
4

Keyword Occurance

Similar Publications

DIGIROP efficacy for detecting treatment-requiring retinopathy of prematurity in a Portuguese cohort.

Authors:
Ana C Almeida Luís Miguel Borrego Margarida Brízido Melissa Brigham de Figueiredo Filipa Teixeira Constança Coelho Susana Teixeira

Eye (Lond) 2021 Mar 12. Epub 2021 Mar 12.

LUZ Saúde, Hospital da Luz de Lisboa, Lisbon, Portugal.

Background/objectives: To determine the efficacy of the DIGIROP model in detecting treatment-requiring retinopathy of prematurity (TR-ROP) in a Portuguese cohort.

Subjects/methods: Multicentre, retrospective cohort study of all consecutive preterm infants who underwent ROP screening from April 2012 to May 2019 in two neonatal units. Gestational age (GA), birth weight (BW) and sex were inserted in the DIGIROP platform. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Outcome of 532 nm Nd:YAG laser photocoagulation in retinopathy of prematurity from a referral center.

Authors:
Selcuk Sizmaz Ebru Esen Nuhkan Gorkemli Ayna Sariyeva Nihal Demircan

Clin Exp Optom 2021 Feb 12:1-5. Epub 2021 Feb 12.

Department of Ophthalmology, School of Medicine, Cukurova University , Adana, Turkey.

: Retinopathy of prematurity is a preventable blinding disorder worldwide. Laser photocoagulation is said to be the gold standard care of treatment. However, various factors are known to affect the outcome. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Incidence, Risk Factors and Screening Evaluation of Retinopathy of Prematurity in High Birthweight Infants: A Large Cohort Study in Turkey.

Authors:
Volkan Dericioğlu Sedat Butur Hande Celiker Özlem Şahin

Ophthalmic Epidemiol 2021 Mar 7:1-7. Epub 2021 Mar 7.

Ophthalmology Department, Marmara University School of Medicine, Istanbul, Turkey.

: To report and evaluate the incidence and risk factors of retinopathy of prematurity (ROP) and to assess the sensitivity and specificity of Turkish national screening guideline (NSG) in heavier infants with a birth weight (BW) of >1500 g. The data of 1784 preterm infants with BW>1500 g, who were screened between 2009 and 2016 in a university hospital in Turkey, were analyzed retrospectively. The rates of any stage and severe (treatment-requiring) ROP incidence were investigated. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Applications of Artificial Intelligence for Retinopathy of Prematurity Screening.

Authors:
J Peter Campbell Praveer Singh Travis K Redd James M Brown Parag K Shah Prema Subramanian Renu Rajan Nita Valikodath Emily Cole Susan Ostmo R V Paul Chan Narendran Venkatapathy Michael F Chiang Jayashree Kalpathy-Cramer

Pediatrics 2021 Mar;147(3)

Athinoula A. Martinos Center for Biomedical Imaging and Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts.

Objectives: Childhood blindness from retinopathy of prematurity (ROP) is increasing as a result of improvements in neonatal care worldwide. We evaluate the effectiveness of artificial intelligence (AI)-based screening in an Indian ROP telemedicine program and whether differences in ROP severity between neonatal care units (NCUs) identified by using AI are related to differences in oxygen-titrating capability.

Methods: External validation study of an existing AI-based quantitative severity scale for ROP on a data set of images from the Retinopathy of Prematurity Eradication Save Our Sight ROP telemedicine program in India. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial.

Authors:
Zhenquan Wu Jinfeng Zhao Waiching Lam Mingmin Yang Lu Chen Xuelin Huang Meirong Wei Hui Yang Fan Lv Fuyan Zhang Jian Zeng Guo-Ming Zhang

Br J Ophthalmol 2021 Feb 26. Epub 2021 Feb 26.

Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China

Purpose: To compare the recurrence rate and surgical complications of retinopathy of prematurity (ROP) between patients treated with intravitreal injection of conbercept (IVC) and intravitreal injection of ranibizumab (IVR) within 6 months.

Methods: A multicentral prospective, randomised controlled trial was applied from May 2017 to February 2019 for the infants diagnosed as aggressive posterior-ROP, zone I or posterior zone II treatment-requiring ROP by binocular indirect ophthalmoscope and RetCam3. These infants were assigned to randomly receive either intravitreal injection of 0. Read More

View Article and Full-Text PDF
February 2021
Similar Publications